FARALLON CAPITAL MANAGEMENT LLC
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 909661
SAN FRANCISCO, CA
Position in ENTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,257,385
-$1,014,232 QoQ
Shares Held
2,418,202
-15.8% QoQ
Ownership
8.30%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#4
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $7,398,148,665 across 26 Biotechnology names. ENTA ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,670,881 | $2,537,793,074 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
10,743,063 | $800,143,332 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $778,248,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,468,010 | $732,794,424 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
14,309,000 | $506,395,510 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
12,277,000 | $383,779,020 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,236,396 | $351,313,110 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,989,098 | $336,372,047 |
All Filings in ENTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,257,385 | 2,418,202 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $36,271,617 | 2,871,862 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $43,718,571 | 2,772,262 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $25,403,476 | 2,122,262 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $16,044,300 | 2,122,262 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $11,714,886 | 2,122,262 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $12,122,506 | 2,108,262 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $21,841,594 | 2,108,262 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $27,172,150 | 2,095,000 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $36,578,700 | 2,095,000 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $19,055,250 | 2,025,000 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $20,943,750 | 1,875,000 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $40,125,000 | 1,875,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $62,682,000 | 1,550,000 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $72,106,000 | 1,550,000 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $80,398,500 | 1,550,000 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $73,268,500 | 1,550,000 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $110,329,000 | 1,550,000 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $117,690,932 | 1,573,829 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $113,335,950 | 1,995,000 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $87,799,950 | 1,995,000 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $98,393,400 | 1,995,000 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $74,727,500 | 1,775,000 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $81,259,500 | 1,775,000 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $87,867,500 | 1,750,000 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $90,002,500 | 1,750,000 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||